Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2994)
All Articles published online
|
May 28, 2006 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gallo A, Cha C. Updates on esophageal and gastric cancers. World J Gastroenterol 2006; 12(20): 3237-3242 [PMID: 16718845 DOI: 10.3748/wjg.v12.i20.3237] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i20/3237.htm |
| Number | Citing Articles |
| 1 |
He Li, Kun Yue. Comparison of Outcomes Between Laparoscopic and Open Spleen-Preserving Gastrectomy in D2 Radical Gastrectomy of Upper and/or the Middle of the Stomach: a Systematic Review and Meta-analysis. Indian Journal of Surgery 2022; 84(5): 922 doi: 10.1007/s12262-021-03207-0
|
| 2 |
Hongchang Shen, Xin Li, Long Meng, Yang Ni, Guanghui Wang, Wei Dong, Jiajun Du. Confirmation of histology of PET positive lymph nodes recovered by hand-video-assisted thoracoscopy surgery. Gene 2012; 509(1): 173 doi: 10.1016/j.gene.2012.07.060
|
| 3 |
Bo Tan, Min Wang, Xi Chen, JiangLong Hou, XiaoHe Chen, Yue Wang, Jesse Li-Ling, HuiQi Xie. Tissue engineered esophagus by copper—small intestinal submucosa graft for esophageal repair in a canine model. Science China Life Sciences 2014; 57(2): 248 doi: 10.1007/s11427-013-4603-0
|
| 4 |
Silvia Baiguera, Luca Urbani, Costantino Del Gaudio. Tissue Engineered Scaffolds for an Effective Healing and Regeneration: Reviewing Orthotopic Studies. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/398069
|
| 5 |
P. S. Diop, J. M. Ndoye, D. Ndiaye, I. Ka, J. M. Dangou, B. Fall. Cancer de l’œsophage au Sénégal: revue d’une série de 72 cas. Journal Africain d'Hépato-Gastroentérologie 2009; 3(4): 190 doi: 10.1007/s12157-009-0115-8
|
| 6 |
Wing-lok Chan, Kwok-keung Yuen, Steven Wai-kwan Siu, Ka-on Lam, Dora Lai-wan Kwong. Third-line systemic treatment versus best supportive care for advanced/metastatic gastric cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2017; 116: 68 doi: 10.1016/j.critrevonc.2017.05.002
|
| 7 |
Ru-Lin Miao, Ai-Wen Wu. Towards personalized perioperative treatment for advanced gastric cancer. World Journal of Gastroenterology 2014; 20(33): 11586-11594 doi: 10.3748/wjg.v20.i33.11586
|
| 8 |
Dexin Zhang, Daiming Fan. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Review of Anticancer Therapy 2007; 7(10): 1369 doi: 10.1586/14737140.7.10.1369
|
| 9 |
Taisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, Takeshi Kubota, Kazuma Okamoto, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Ryo Morimura, Yasutoshi Murayama, Yoshiaki Kuriu, Hisashi Ikoma, Masayoshi Nakanishi, Chouhei Sakakura, Eigo Otsuji. Poor prognostic subgroup in T3N0 stage IIA gastric cancer, suggesting an indication for adjuvant chemotherapy. Journal of Surgical Oncology 2015; 111(2): 221 doi: 10.1002/jso.23796
|
| 10 |
Xi Cheng, Shan Yu, Yan Wang, Yuehong Cui, Wei Li, Yiyi Yu, Cheng Tang, Huiqin Jiang, Yuan Ji, Yihong Sun, Xuefei Wang, Zhenbin Shen, Fenglin Liu, Tian-shu Liu. The role of oxaliplatin in the adjuvant setting of different Lauren’s type of gastric adenocarcinoma after D2 gastrectomy: a real-world study. Gastric Cancer 2019; 22(3): 587 doi: 10.1007/s10120-018-0895-x
|
| 11 |
Neha Saroha, Mohammed Afroz Ahamed. Histopathological study of neoplastic lesions of upper gastrointestinal tract endoscopic biopsies. Indian Journal of Pathology and Oncology 2022; 9(1): 43 doi: 10.18231/j.ijpo.2022.010
|
| 12 |
J.J. Xie, L.Y. Xu, Z.Y. Wu, L.Y. Li, X.E. Xu, J.Y. Wu, Q. Huang, E.M. Li. Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma. European Journal of Surgical Oncology (EJSO) 2011; 37(8): 669 doi: 10.1016/j.ejso.2011.05.009
|
| 13 |
Dimitra Florou, Konstantinos Mavridis, Andreas Scorilas. The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents. Tumor Biology 2012; 33(6): 2069 doi: 10.1007/s13277-012-0466-4
|
| 14 |
Xiushan Zheng, Yunping Zhao, Xin Wang, Yunming Li, Ruwen Wang, Yaoguang Jiang, Taiqian Gong, Mengbin Li, Li Sun, Liu Hong, Xiaohua Li, Jie Liang, Guanhong Luo, Bin Jin, Jianjun Yang, Hongwei Zhang, Daiming Fan. Decreased Expression of CIAPIN1 Is Correlated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma. Digestive Diseases and Sciences 2010; 55(12): 3408 doi: 10.1007/s10620-010-1212-7
|
| 15 |
Wen Ming Feng, Cheng Wu Tang, Hui Hui Guo, Ying Bao, Mao Yun Fei. Prolonged adjuvant capecitabine chemotherapy improved survival of stage IIIA gastric cancer after D2 gastrectomy. Biomedicine & Pharmacotherapy 2015; 72: 140 doi: 10.1016/j.biopha.2015.03.003
|
| 16 |
Jun Eul Hwang, Myung Seo Ki, Karham Kim, Sung-Hoon Jung, Hyun-Jeong Shim, Woo-Kyun Bae, Eu-Chang Hwang, Young Hoe Hur, Oh Jeong, Seong Yeob Ryu, Young Kyu Park, Sang-Hee Cho, Ju-Seog Lee, Ik-Joo Chung. The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis. Oncotarget 2017; 8(39): 66559 doi: 10.18632/oncotarget.16301
|
| 17 |
Jong Gwang Kim, Baek-Yeol Ryoo, Yeon Hee Park, Bong-Seog Kim, Tae-You Kim, Young-Hyuck Im, Yoon-Koo Kang. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy. Cancer Chemotherapy and Pharmacology 2007; 61(2): 301 doi: 10.1007/s00280-007-0476-x
|
| 18 |
ONGCHANG SHEN, JUE WANG, WENHUAN LI, WEIWEI YI, WEIBO WANG. Assessment of health-related quality of life of patients with esophageal squamous cell carcinoma following esophagectomy using EORTC quality of life questionnaires. Molecular and Clinical Oncology 2015; 3(1): 133 doi: 10.3892/mco.2014.434
|
| 19 |
Yung-Jue Bang, Young-Woo Kim, Han-Kwang Yang, Hyun Cheol Chung, Young-Kyu Park, Kyung Hee Lee, Keun-Wook Lee, Yong Ho Kim, Sang-Ik Noh, Jae Yong Cho, Young Jae Mok, Yeul Hong Kim, Jiafu Ji, Ta-Sen Yeh, Peter Button, Florin Sirzén, Sung Hoon Noh. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. The Lancet 2012; 379(9813): 315 doi: 10.1016/S0140-6736(11)61873-4
|
| 20 |
Wing-lok Chan, Ka-on Lam, Tsz-him So, Victor Ho-fun Lee, Lai-wan Dora Kwong. Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review. Therapeutic Advances in Medical Oncology 2019; 11: 175883591985999 doi: 10.1177/1758835919859990
|
| 21 |
P Sun, J-B Xiang, Z-Y Chen. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. British Journal of Surgery 2008; 96(1): 26 doi: 10.1002/bjs.6408
|
| 22 |
Fenghua Guo, Shulan Ma, Shuo Yang, Yuanqiang Dong, Fen Luo, Zhiming Wang. Surgical strategy for gastric cancer patients with liver cirrhosis: A retrospective cohort study. International Journal of Surgery 2014; 12(8): 810 doi: 10.1016/j.ijsu.2014.06.011
|
| 23 |
Tracy E Slanger, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Katrin Jensen, Meinhard Kieser, Ulrich Ronellenfitsch, Ulrich Ronellenfitsch. Cochrane Database of Systematic Reviews. 2009; doi: 10.1002/14651858.CD008107
|
| 24 |
Yoko Murayama, Kenji Oritani, Shusaku Tsutsui. Novel CD9-targeted therapies in gastric cancer. World Journal of Gastroenterology 2015; 21(11): 3206-3213 doi: 10.3748/wjg.v21.i11.3206
|
| 25 |
Kai Fu, Bingqing Hui, Qian Wang, Chen Lu, Weihong Shi, Zhigang Zhang, Dawei Rong, Betty Zhang, Zhaofeng Tian, Weiwei Tang, Hongyong Cao, Xuehao Wang, Ziyi Chen. Single-cell RNA sequencing of immune cells in gastric cancer patients. Aging 2020; 12(3): 2747 doi: 10.18632/aging.102774
|
| 26 |
Jian-Jun Xie, Yang-Min Xie, Bo Chen, Feng Pan, Jin-Cheng Guo, Qing Zhao, Jin-Hui Shen, Zhi-Yong Wu, Jian-Yi Wu, Li-Yan Xu, En-Min Li. ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma. Oncotarget 2014; 5(18): 8569 doi: 10.18632/oncotarget.2322
|
| 27 |
Hongyan Ren, Xia Wan, Fei Yang, Xiaoming Shi, Jianwei Xu, Dafang Zhuang, Gonghuan Yang. Association between Changing Mortality of Digestive Tract Cancers and Water Pollution: A Case Study in the Huai River Basin, China. International Journal of Environmental Research and Public Health 2014; 12(1): 214 doi: 10.3390/ijerph120100214
|
| 28 |
Nikolay Alabi, Dropen Sheka, Ashar Siddiqui, Edwin Wang. Methylation-Based Signatures for Gastroesophageal Tumor Classification. Cancers 2020; 12(5): 1208 doi: 10.3390/cancers12051208
|
| 29 |
Ranjit S. Ambad, Priya Koundal, Akansha Singh, Roshan Kumar Jha. Association between Glutathione-S-Transferase and Gastric Carcinoma: A Case Control Study. Journal of Evolution of Medical and Dental Sciences 2020; 9(38): 2783 doi: 10.14260/jemds/2020/606
|
| 30 |
Jang Ho Cho, Jae Yun Lim, Jae Yong Cho, Masaru Katoh. Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy. PLOS ONE 2017; 12(10): e0186362 doi: 10.1371/journal.pone.0186362
|
| 31 |
Shinichi Umeda, Mitsuro Kanda, Takashi Miwa, Haruyoshi Tanaka, Chie Tanaka, Daisuke Kobayashi, Masaya Suenaga, Norifumi Hattori, Masamichi Hayashi, Suguru Yamada, Goro Nakayama, Michitaka Fujiwara, Yasuhiro Kodera. Expression of sushi domain containing two reflects the malignant potential of gastric cancer. Cancer Medicine 2018; 7(10): 5194 doi: 10.1002/cam4.1793
|
| 32 |
Dong Hoe Koo, Baek-Yeol Ryoo, Hwa Jung Kim, Min-Hee Ryu, Sung-Sook Lee, Jung-Hwa Moon, Heung-Moon Chang, Jae-Lyun Lee, Tae Won Kim, Yoon-Koo Kang. A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models. Cancer Chemotherapy and Pharmacology 2011; 68(4): 913 doi: 10.1007/s00280-011-1561-8
|
| 33 |
Joong Ho Lee, Kyung Min Kim, Jae-Ho Cheong, Sung Hoon Noh. Current Management and Future Strategies of Gastric Cancer. Yonsei Medical Journal 2012; 53(2): 248 doi: 10.3349/ymj.2012.53.2.248
|
| 34 |
Keiji Nishibeppu, Shuhei Komatsu, Taisuke Imamura, Jun Kiuchi, Takuma Kishimoto, Tomohiro Arita, Toshiyuki Kosuga, Hirotaka Konishi, Takeshi Kubota, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Eigo Otsuji. Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59939-8
|
| 35 |
Ulrich Ronellenfitsch, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Meinhard Kieser, Tracy E. Slanger, Bryan Burmeister, David Kelsen, Donna Niedzwiecki, Christoph Schuhmacher, Susan Urba, Cornelis van de Velde, Thomas N. Walsh, Marc Ychou, Katrin Jensen. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data. European Journal of Cancer 2013; 49(15): 3149 doi: 10.1016/j.ejca.2013.05.029
|
| 36 |
Hayato Baba, Mitsuro Kanda, Koichi Sawaki, Shinichi Umeda, Takashi Miwa, Dai Shimizu, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Yasuhiro Kodera, Tsutomu Fujii. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer. Annals of Surgical Oncology 2020; 27(6): 2071 doi: 10.1245/s10434-019-07985-6
|
| 37 |
Jae-Seok Min, Chang Min Lee, Sung Il Choi, Kyung Won Seo, Do Joong Park, Yong Hae Baik, Myoung-Won Son, Won Hyuk Choi, Sungsoo Kim, Kyung Ho Pak, Min Gyu Kim, Joong-Min Park, Sang Ho Jeong, Moon-Soo Lee, Sungsoo Park. Who Can Perform Adjuvant Chemotherapy Treatment for Gastric Cancer? A Multicenter Retrospective Overview of the Current Status in Korea. Journal of Gastric Cancer 2018; 18(3): 264 doi: 10.5230/jgc.2018.18.e29
|
| 38 |
LIN YANG, YI YANG, QIONG QIN, AIPING ZHOU, JIANJUN ZHAO, JINWAN WANG, CHANG SHU, XINGHUA YUAN, SONGNIAN HU. Evaluation of the optimal dosage of S-1 in adjuvant SOX chemotherapy for gastric cancer. Oncology Letters 2015; 9(3): 1451 doi: 10.3892/ol.2014.2821
|
| 39 |
Rosa Ana Risques, Thomas L. Vaughan, Xiaohong Li, Robert D. Odze, Patricia L. Blount, Kamran Ayub, Jasmine L. Gallaher, Brian J. Reid, Peter S. Rabinovitch. Leukocyte Telomere Length Predicts Cancer Risk in Barrett's Esophagus. Cancer Epidemiology, Biomarkers & Prevention 2007; 16(12): 2649 doi: 10.1158/1055-9965.EPI-07-0624
|
| 40 |
Weiwei Tang, Xiongxiong Pan, Di Han, Dawei Rong, Minghui Zhang, Lulu Yang, Jie Ying, Hua Guan, Ziyi Chen, Xuehao Wang. Clinical significance of CD8+ T cell immunoreceptor with Ig and ITIM domains+ in locally advanced gastric cancer treated with SOX regimen after D2 gastrectomy. OncoImmunology 2019; 8(6): e1593807 doi: 10.1080/2162402X.2019.1593807
|
| 41 |
Rikke Baastrup, Mette Sørensen, Johnni Hansen, Rikke Dalgaard Hansen, Hanne Würtzen, Jeanette Falck Winther. Social inequality and incidence of and survival from cancers of the oesophagus, stomach and pancreas in a population-based study in Denmark, 1994–2003. European Journal of Cancer 2008; 44(14): 1962 doi: 10.1016/j.ejca.2008.06.013
|
| 42 |
Yuping Peng, Xuning Shen, Honggang Jiang, Zhiheng Chen, Jiaming Wu, Yi Zhu, Yuan Zhou, Jin Li. miR-188-5p Suppresses Gastric Cancer Cell Proliferation and Invasion via Targeting ZFP91. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 27(1): 65 doi: 10.3727/096504018X15191223015016
|
| 43 |
Raquel C. Montenegro, Peter G.K. Clark, Alison Howarth, Xiao Wan, Alessandro Ceroni, Paulina Siejka, Graciela A. Nunez-Alonso, Octovia Monteiro, Catherine Rogers, Vicki Gamble, Rommel Burbano, Paul E. Brennan, Cynthia Tallant, Daniel Ebner, Oleg Fedorov, Eric O’Neill, Stefan Knapp, Darren Dixon, Susanne Müller. BET inhibition as a new strategy for the treatment of gastric cancer. Oncotarget 2016; 7(28): 43997 doi: 10.18632/oncotarget.9766
|
| 44 |
Jianping He, Feng Wen, Xude Yin, Pengfei Zhang, Zedong Du, Xiaofeng He, Yi Zhou, Ruilei Tang, Meng Li, Qiu Li. Cost analysis of S1 and XELOX as adjuvant therapy for gastric cancer. Anti-Cancer Drugs 2013; 24(7): 754 doi: 10.1097/CAD.0b013e328361bef2
|
| 45 |
Bo Tan, Ren-Qian Wei, Mei-Yun Tan, Jing-Cong Luo, Li Deng, Xiao-He Chen, Jiang-Long Hou, Xiu-Qun Li, Zhi-Ming Yang, Hui-Qi Xie. Tissue engineered esophagus by mesenchymal stem cell seeding for esophageal repair in a canine model. Journal of Surgical Research 2013; 182(1): 40 doi: 10.1016/j.jss.2012.07.054
|
| 46 |
Dimitra Florou, Christos Patsis, Alexandros Ardavanis, Andreas Scorilas. Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity ofBCL-2family gene members in stomach cancer cells. Cancer Biology & Therapy 2013; 14(7): 587 doi: 10.4161/cbt.24591
|
| 47 |
Siqi Zhou, Shu Zhang, Lei Wang, Shuling Huang, Yue Yuan, Jie Yang, Hui Wang, Xihan Li, Pin Wang, Lin Zhou, Jun Yang, Yuemei Xu, Huan Gao, Yixuan Zhang, Ying Lv, Xiaoping Zou. BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling. Oncogenesis 2020; 9(3) doi: 10.1038/s41389-020-0218-z
|
| 48 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; : 125 doi: 10.1007/978-3-031-10839-6_5
|
| 49 |
Ulrich Ronellenfitsch, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Meinhard Kieser, Tracy E Slanger, Katrin Jensen. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD008107.pub2
|
| 50 |
Yan-Hong Wang, Zu-Bang Zhou, Chang-An Guo, Jing Zhai, Fa-Mei Qi, Hong-Ling Li. Role of mimic of manganese superoxide dismutase in proliferation and apoptosis of gastric carcinoma BGC-823 cells in vitro and in vivo. International Immunopharmacology 2015; 26(2): 277 doi: 10.1016/j.intimp.2015.04.003
|
| 51 |
Long Ge, Liangying Hou, Qingxia Yang, Yiting Wu, Xiue Shi, Jiang Li, Kehu Yang. A systematic review and network meta-analysis protocol of adjuvant chemotherapy regimens for resected gastric cancer. Medicine 2019; 98(7): e14478 doi: 10.1097/MD.0000000000014478
|
| 52 |
A. Lamarca Lete, R. Molina Villaverde, F. Navarro Expósito, M. Álvarez-Mon Soto. Cáncer de estómago. Medicine - Programa de Formación Médica Continuada Acreditado 2013; 11(25): 1512 doi: 10.1016/S0304-5412(13)70487-6
|
| 53 |
Nivedita Basu, Halcyon G Skinner, Kristin Litzelman, Russell Vanderboom, Esha Baichoo, Lisa A Boardman. Telomeres and telomere dynamics: relevance to cancers of the GI tract. Expert Review of Gastroenterology & Hepatology 2013; 7(8): 733 doi: 10.1586/17474124.2013.848790
|
| 54 |
So-Young Seol, Chul Kim, Jae Yun Lim, Sun Och Yoon, Soon Won Hong, Jong Won Kim, Seung Ho Choi, Jae Yong Cho. Overexpression of Endoplasmic Reticulum Oxidoreductin 1-α (ERO1L) Is Associated with Poor Prognosis of Gastric Cancer. Cancer Research and Treatment 2016; 48(4): 1196 doi: 10.4143/crt.2015.189
|
| 55 |
Lu-Ying Liu, Yan-Chun Han, Shu-Hua Wu, Zeng-Hua Lv. Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer. World Journal of Gastroenterology 2008; 14(13): 2110-2114 doi: 10.3748/wjg.14.2110
|
| 56 |
Ren-Qian Wei, Bo Tan, Mei-Yun Tan, Jing-Cong Luo, Li Deng, Xiao-He Chen, Xiu-Qun Li, Xiao Zuo, Wei Zhi, Peng Yang, Hui-Qi Xie, Zhi-Ming Yang. Grafts of Porcine Small Intestinal Submucosa with Cultured Autologous Oral Mucosal Epithelial Cells for Esophageal Repair in a Canine Model. Experimental Biology and Medicine 2009; 234(4): 453 doi: 10.3181/0901-RM-5
|
| 57 |
Melissa J. LaBonte, Philipp C. Manegold, Peter M. Wilson, Will Fazzone, Stan G. Louie, Heinz‐Josef Lenz, Robert D. Ladner. The dual EGFR/HER‐2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN‐38. International Journal of Cancer 2009; 125(12): 2957 doi: 10.1002/ijc.24658
|
| 58 |
Choong-kun Lee, Minkyu Jung, Inkyung Jung, Su Jin Heo, Yong Hyu Jeong, Ji Yeong An, Hyoung-Il Kim, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Hyo Song Kim, Sun Young Rha, Hyun Cheol Chung. Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy. Annals of Surgery 2016; 263(1): 96 doi: 10.1097/SLA.0000000000001086
|
| 59 |
Jianfeng Huang, Wenzheng Chen, Zhigang Jie, Mengmeng Jiang. Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.820568
|
| 60 |
Jan Beyer-Westendorf, Sebastian Werth, Kai Halbritter, Norbert Weiss. Cancer in males and risk of venous thromboembolism. Thrombosis Research 2010; 125: S155 doi: 10.1016/S0049-3848(10)70035-9
|
| 61 |
Ji Feng, Yin Xu, Zhouling Wei, Yiju Xia, Haoxiang Zhang, Caifei Shen, Pu Wang, Wu Yan, Dianchun Fang, Yu Fang. Capsaicin inhibits migration and invasion via inhibiting epithelial-mesenchymal transition in esophageal squamous cell carcinoma by up-regulation of claudin-3 expression. Journal of Functional Foods 2022; 89: 104934 doi: 10.1016/j.jff.2022.104934
|
| 62 |
Liu Cao, Xiaoling Xu, Longyue L. Cao, Rui-Hong Wang, Xavier Coumoul, Sang S. Kim, Chu-Xia Deng. Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach. Carcinogenesis 2007; 28(7): 1401 doi: 10.1093/carcin/bgm060
|
| 63 |
NING ZHOU, YANLI QU, CHUNLEI XU, YONG TANG. Upregulation of microRNA-375 increases the cisplatin-sensitivity of human gastric cancer cells by regulating ERBB2. Experimental and Therapeutic Medicine 2016; 11(2): 625 doi: 10.3892/etm.2015.2920
|
| 64 |
Lei Jiang, Ke-hu Yang, Quan-lin Guan, Yan Chen, Peng Zhao, Jin-hui Tian. Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal Junction. Journal of Clinical Gastroenterology 2015; 49(5): 387 doi: 10.1097/MCG.0000000000000212
|
| 65 |
In-Hwan Kim, Sung-Soo Park, Chang-Min Lee, Min Chan Kim, In-Kyu Kwon, Jae-Seok Min, Hyoung-Il Kim, Han Hong Lee, Sang-Il Lee, Hyundong Chae. Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study. Annals of Surgical Oncology 2018; 25(5): 1176 doi: 10.1245/s10434-018-6375-z
|
| 66 |
Jinchul Kim, Seonggyu Byeon, Hyera Kim, Ja Hyun Yeo, Jung Yong Hong, Jeeyun Lee, Ho Yeong Lim, Won Ki Kang, Seung Tae Kim. Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients. Targeted Oncology 2020; 15(2): 203 doi: 10.1007/s11523-020-00713-1
|
| 67 |
Taisei Nakamoto, Yoko Murayama, Kenji Oritani, Claude Boucheix, Eric Rubinstein, Makoto Nishida, Fumie Katsube, Kenji Watabe, Shinichi Kiso, Shusaku Tsutsui, Shinji Tamura, Yasuhisa Shinomura, Norio Hayashi. A novel therapeutic strategy with anti-CD9 antibody in gastric cancers. Journal of Gastroenterology 2009; 44(9): 889 doi: 10.1007/s00535-009-0081-3
|
| 68 |
Dapeng Lin, Ping Lu, Caigang Liu, Huimian Xu, Shubao Wang, Junqing Chen. Clinicopathologic characteristics and surgical outcome of gastric cancer in patients younger than 36 years of age. Clinical Oncology and Cancer Research 2009; 6(4): 263 doi: 10.1007/s11805-009-0263-z
|
| 69 |
Rohit Upadhyay, Meenu Jain, Shaleen Kumar, Uday Chand Ghoshal, Balraj Mittal. Association of interleukin-6 (−174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: An exploratory study. Clinical Immunology 2008; 128(2): 199 doi: 10.1016/j.clim.2008.03.519
|
| 70 |
Takuma Ohashi, Shuhei Komatsu, Daisuke Ichikawa, Toshiyuki Kosuga, Kazuma Okamoto, Tomohiro Arita, Hirotaka Konishi, Ryo Morimura, Yasutoshi Murayama, Atsushi Shiozaki, Yoshiaki Kuriu, Hisashi Ikoma, Masayoshi Nakanishi, Hitoshi Fujiwara, Eigo Otsuji. Monitoring with sensitive tumor markers contributes to decision-making and better prognosis in gastric cancer patients with peritoneal recurrence. International Journal of Clinical Oncology 2017; 22(5): 897 doi: 10.1007/s10147-017-1132-z
|
| 71 |
Keiji Nishibeppu, Shuhei Komatsu, Daisuke Ichikawa, Taisuke Imamura, Toshiyuki Kosuga, Kazuma Okamoto, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Eigo Otsuji. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4052-z
|
| 72 |
Florian Struller, Philipp Horvath, Wiebke Solass, Frank-Jürgen Weinreich, Dirk Strumberg, Marios K. Kokkalis, Imma Fischer, Christoph Meisner, Alfred Königsrainer, Marc A. Reymond. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study. Therapeutic Advances in Medical Oncology 2019; 11: 175883591984640 doi: 10.1177/1758835919846402
|
| 73 |
Matthias Ebert, Xiangbin Xing, Elke Burgermeister, Roland Schmid, Christoph Röcken. Perspectives of clinical proteomics in gastrointestinal cancer. Expert Review of Anticancer Therapy 2007; 7(4): 465 doi: 10.1586/14737140.7.4.465
|
| 74 |
Jin-tang Xia, Lian-zhou Chen, Wei-hua Jian, Ke-Bing Wang, Yong-zhen Yang, Wei-ling He, Yu-long He, De Chen, Wen Li. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/1479-5876-12-33
|
| 75 |
Sungshim Lani Park, Shen-Chih Chang, Lin Cai, Carlos Cordon-Cardo, Bao-Guo Ding, Sander Greenland, Shehnaz K. Hussain, Qingwu Jiang, Simin Liu, Ming-Lan Lu, Jenny T. Mao, Hal Morgenstern, Li-Na Mu, Leslie J. Ng, Allan Pantuck, Jianyu Rao, Victor E. Reuter, Donald P. Tashkin, Nai-Chieh Y. You, Can-Qing Yu, Shun-Zhang Yu, Jin-Kou Zhao, Arie Belldegrun, Zuo-Feng Zhang. Associations between Variants of the 8q24 Chromosome and Nine Smoking-Related Cancer Sites. Cancer Epidemiology, Biomarkers & Prevention 2008; 17(11): 3193 doi: 10.1158/1055-9965.EPI-08-0523
|
| 76 |
Catherine J. Rees, Peter C. Belafsky. Gastric Carcinoma. Ear, Nose & Throat Journal 2007; 86(4): 210 doi: 10.1177/014556130708600410
|
| 77 |
Enrico Benzoni, Vittorio Bresadola, Giovanni Terrosu, Alessandro Uzzau, Carla Cedolini, Sergio Intini, Luigi Noce, Fabrizio Bresadola. Minimally Invasive Esophagectomy. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2008; 18(2): 178 doi: 10.1097/SLE.0b013e318165f205
|
| 78 |
Liana Kumar, Feruza Kholmurodova, Jeff Bull, Tim Bright, David I. Watson, Jonathan Shenfine. Comparison of oesophageal and gastric cancer in the evaluation of urgent endoscopy referral criteria. ANZ Journal of Surgery 2021; 91(7-8): 1515 doi: 10.1111/ans.16984
|
| 79 |
Shan Yu, Yan Wang, Xi Cheng, Minzhi Lv, Yuehong Cui, Wei Li, Yiyi Yu, Qian Li, Tianshu Liu. <p>Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients</p>. Cancer Management and Research 2020; : 10091 doi: 10.2147/CMAR.S270387
|
| 80 |
Hironaga Satake, Akira Miki, Masato Kondo, Takeshi Kotake, Yoshihiro Okita, Yukimasa Hatachi, Hisateru Yasui, Yukihiro Imai, Chihiro Ichikawa, Kenta Murotani, Hiroki Hashida, Hiroyuki Kobayashi, Masahito Kotaka, Takeshi Kato, Satoshi Kaihara, Akihito Tsuji. Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI). ESMO Open 2017; 2(1): e000130 doi: 10.1136/esmoopen-2016-000130
|
| 81 |
Jingting Jiang, Changping Wu, Liangrong Shi, Ning Xu, Haifeng Deng, Mingyang Lu, Mei Ji, Yibei Zhu, Xueguang Zhang. Side effects during treatment of advanced gastric carcinoma by chemotherapy combined with CIK-cell transfusion in elderly people. Chinese Journal of Clinical Oncology 2008; 5(2): 79 doi: 10.1007/s11805-008-0079-2
|
| 82 |
Guo-Qing Li, Juan Xie, Xiao-Yong Lei, Li Zhang. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells <italic>via</italic> the PI3K/Akt pathway. World Journal of Gastroenterology 2009; 15(44): 5541-5548 doi: 10.3748/wjg.15.5541
|
| 83 |
Zhandong Zhang, Ye Kong, Wei Yang, Fei Ma, Yonglei Zhang, Sheqing Ji, ER-Min Ma, Hongxing Liu, Yongshun Chen, Yawei Hua. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET. Oncology Reports 2016; 36(4): 2391 doi: 10.3892/or.2016.5016
|
| 84 |
Mei-Rong Fan, Mei Gong, Lin-Cui Da, Lin Bai, Xiu-Qun Li, Ke-Fei Chen, Jesse Li-Ling, Zhi-Ming Yang, Hui-Qi Xie. Tissue engineered esophagus scaffold constructed with porcine small intestinal submucosa and synthetic polymers. Biomedical Materials 2014; 9(1): 015012 doi: 10.1088/1748-6041/9/1/015012
|
| 85 |
Choong-kun Lee, Minkyu Jung, Hyo Song Kim, Inkyung Jung, Dong Bok Shin, Seok Yun Kang, Dae Young Zang, Ki Hyang Kim, Moon Hee Lee, Bong-Seog Kim, Kyung Hee Lee, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Hyun Cheol Chung, Sun Young Rha. S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial. Cancer Research and Treatment 2019; 51(1): 1 doi: 10.4143/crt.2018.028
|
| 86 |
Yu Han Zhao, Yu Zheng, Jie Sha, Hong Jin Hua, Ke Dong Li, Yu Lu, Yi Ni Dang, Guo Xin Zhang. A Prediction Model Based on the Risk Factors Associated with Pathological Upgrading in Patients with Early-Stage Gastric Neoplasms Diagnosed by Endoscopic Forceps Biopsy. Gut and Liver 2023; 17(1): 78 doi: 10.5009/gnl220060
|
| 87 |
Junming Guo, Bingxiu Xiao, Qiong Liu, Zhaohui Gong, Yanping Le. Suppression of C-myc Expression Associates with Anti-Proliferation of Aloe-Emodin on Gastric Cancer Cells. Cancer Investigation 2008; 26(4): 369 doi: 10.1080/07357900701788130
|